Scarica l'app Stockscreener
2.03
0.00%
0.00
Dopo l'orario di chiusura:
2.05
0.02
+0.99%
Precedente Chiudi:
$2.03
Aprire:
$2.01
Volume 24 ore:
148.68K
Relative Volume:
0.52
Capitalizzazione di mercato:
$48.70M
Reddito:
-
Utile/perdita netta:
$-13.76M
Rapporto P/E:
-2.1828
EPS:
-0.93
Flusso di cassa netto:
-
1 W Prestazione:
+5.18%
1M Prestazione:
+6.84%
6M Prestazione:
+95.19%
1 anno Prestazione:
+150.81%
Intervallo 1D:
$1.92
$2.04
Intervallo di 1 settimana:
$1.825
$2.10
Portata 52W:
$0.5985
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
2.03 | 48.70M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
Why is NeuroSense Therapeutics Ltd. stock attracting strong analyst attentionWealth Building Review That Work - jammulinksnews.com
What makes NeuroSense Therapeutics Ltd. Equity Warrant stock price move sharplyFree Stock Market Return Analysis - jammulinksnews.com
What are NeuroSense Therapeutics Ltd. Equity Warrant company’s key revenue driversBuild wealth faster with expert stock selection - jammulinksnews.com
What is NeuroSense Therapeutics Ltd. Equity Warrant company’s growth strategyOutstanding capital appreciation - jammulinksnews.com
What are the latest earnings results for NeuroSense Therapeutics Ltd. Equity WarrantAchieve breakthrough profits with expert advice - jammulinksnews.com
When is NeuroSense Therapeutics Ltd. Equity Warrant stock expected to show significant growth - jammulinksnews.com
What are analysts’ price targets for NeuroSense Therapeutics Ltd. in the next 12 monthsDynamic investment growth - jammulinksnews.com
How does NeuroSense Therapeutics Ltd. Equity Warrant compare to its industry peersGet daily expert analysis on top stocks - jammulinksnews.com
What institutional investors are buying NeuroSense Therapeutics Ltd. stockSuperior risk-adjusted returns - jammulinksnews.com
Should I hold or sell NeuroSense Therapeutics Ltd. Equity Warrant stock in 2025Build a strong portfolio for growth and safety - jammulinksnews.com
Is it the right time to buy NeuroSense Therapeutics Ltd. stockUnlock powerful stock screening tools - jammulinksnews.com
Published on: 2025-07-27 19:57:04 - jammulinksnews.com
Why NeuroSense Therapeutics Ltd. stock attracts strong analyst attentionMassive Profit Potential - Newser
NeuroSense Therapeutics Ltd. Equity Warrant Company Revenue and Profit Trends: A Deep DiveFree Stock Market Forecasting Tools - Newser
How strong is NeuroSense Therapeutics Ltd. company’s balance sheetGet exclusive access to professional stock picks - jammulinksnews.com
What drives NeuroSense Therapeutics Ltd. stock priceOutstanding yields - PrintWeekIndia
What drives NeuroSense Therapeutics Ltd. Equity Warrant stock priceHigh-yield capital appreciation - PrintWeekIndia
What analysts say about NeuroSense Therapeutics Ltd. stockOutstanding risk-reward balance - Autocar Professional
NeuroSense Therapeutics Ltd. Equity Warrant Stock Analysis and ForecastExceptional profit margins - PrintWeekIndia
Is NeuroSense Therapeutics Ltd. a good long term investmentUnmatched market gains - Autocar Professional
What analysts say about NeuroSense Therapeutics Ltd. stock outlookUnmatched profit growth - jammulinksnews.com
NeuroSense Therapeutics Ltd. Stock Analysis and ForecastExceptional market performance - PrintWeekIndia
Can NeuroSense Therapeutics Ltd. stock recover from recent declineOutstanding risk-reward balance - jammulinksnews.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com
Is NeuroSense Therapeutics Ltd. Equity Warrant a good long term investmentHigh-yield trading alerts - PrintWeekIndia
How NeuroSense Therapeutics Ltd. Equity Warrant stock reacts to Fed policy changesExtraordinary earning power - jammulinksnews.com
What analysts say about NeuroSense Therapeutics Ltd. Equity Warrant stockExplosive market performance - Autocar Professional
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):